BioPharm Asia, Inc. (OTCBB: BFAR; the ?Company?), a producer, distributor and retailer of medicinal and herbal products in China, today announced that it will be utilizing a new organizational structure and new processes to support the expansion of its medical and health care provider services.

The Company expects to enhance both its operating structure and the ability of its Board of Directors to oversee operations and make recommendations based upon their experience. These changes will enable Mr. Li, the Company's newly appointed CEO, to better develop the Company's ability to service China's rapidly expanding health care market, and will require managers to create specific objectives for their departments with subsequent evaluations of progress made against these objectives. Additionally, the Company expects to expand its Board of Directors with the appointment of independent directors who have specific knowledge and experience in the health care market to assist Mr. Li and his management team in developing strategies, including potential acquisitions, to best enable BioPharm Asia to increase its market share in the areas it services and thus its revenue and profit.

BioPharm Asia believes that these adjustments will assist in its efforts to attain its goal of 25% profit growth in 2010.

About BioPharm Asia, Inc.

BioPharm Asia, Inc. is engaged in the retail sale of medicinal and herbal products in China, complemented by vertically integrated supporting functions that include the cultivation of Chinese herbal medicines, pharmaceutical production and wholesale medicine distribution. Following several successful acquisitions, the Company is completing the integration of its distribution channels and expanding its trading business (conducted through its retail stores as well as its distribution activities) to include pharmaceutical manufacturing and the cultivation and sale of medicinal raw materials. For more information, please visit http://www.biopharmasiainc.com.

Forward-looking statement: Except for certain historical information contained herein, the matters discussed in this news release contain forward-looking statements, including, but not limited to, statements relating to future expansion plans, growth in sales and profitability. These forward-looking statements involve a number of risks and uncertainties. Actual results may differ materially from those implied herein due to a number of factors, including, but not limited to, uncertainties in product demand, risks related to doing business in China, the impact of competitive products and pricing, changing economic conditions around the world, release and sales of new products and other risk factors discussed in the company's most recent annual report and other filings with the U. S. Securities and Exchange Commission.

For more information:
BioPharm Asia Inc.
Jianxiong Liu, 011-86-435-5211804
Jianxiong_Liu@biopharmasiaco.com